<html class="gs_el_sm gs_pfcs"><head><title>‪Ingunn Holen‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=9lxA1jEAAAAJ&amp;hl=en"><meta name="description" content="‪University of Sheffield‬ - ‪‪Cited by 9,404‬‬ - ‪Breast Cancer‬ - ‪bone metastases‬ - ‪bone biology‬"><meta property="og:description" content="‪University of Sheffield‬ - ‪‪Cited by 9,404‬‬ - ‪Breast Cancer‬ - ‪bone metastases‬ - ‪bone biology‬"><meta property="og:title" content="Ingunn Holen"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=9lxA1jEAAAAJ&amp;citpid=2"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"qw1SYa3TF5mTy9YPhteQwAE"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=9lxA1jEAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYVNfK8R0lnIHvWSSUwFu1VBKlpVpDf0F"><input type="hidden" name="user" value="9lxA1jEAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">9404</td><td class="gsc_rsb_std">3915</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">57</td><td class="gsc_rsb_std">36</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">104</td><td class="gsc_rsb_std">86</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:930px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:888px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">700</div><div class="gsc_g_xtl" style="top:73px;">350</div><div class="gsc_g_xtl" style="top:113px;">175</div><div class="gsc_g_xtl" style="top:33px;">525</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:154px;height:6px;z-index:27"><span class="gsc_g_al">30</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:154px;height:6px;z-index:26"><span class="gsc_g_al">27</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:151px;height:9px;z-index:25"><span class="gsc_g_al">41</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:146px;height:14px;z-index:24"><span class="gsc_g_al">65</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:155px;height:5px;z-index:23"><span class="gsc_g_al">23</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:143px;height:17px;z-index:22"><span class="gsc_g_al">78</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:151px;height:9px;z-index:21"><span class="gsc_g_al">42</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:143px;height:17px;z-index:20"><span class="gsc_g_al">75</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:128px;height:32px;z-index:19"><span class="gsc_g_al">144</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:126px;height:34px;z-index:18"><span class="gsc_g_al">153</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:117px;height:43px;z-index:17"><span class="gsc_g_al">192</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:112px;height:48px;z-index:16"><span class="gsc_g_al">212</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:99px;height:61px;z-index:15"><span class="gsc_g_al">271</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:96px;height:64px;z-index:14"><span class="gsc_g_al">284</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:72px;height:88px;z-index:13"><span class="gsc_g_al">386</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:43px;height:117px;z-index:12"><span class="gsc_g_al">514</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:38px;height:122px;z-index:11"><span class="gsc_g_al">537</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:30px;height:130px;z-index:10"><span class="gsc_g_al">573</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:33px;height:127px;z-index:9"><span class="gsc_g_al">557</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:40px;height:120px;z-index:8"><span class="gsc_g_al">527</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:18px;height:142px;z-index:7"><span class="gsc_g_al">623</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:2px;height:158px;z-index:6"><span class="gsc_g_al">695</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:18px;height:142px;z-index:5"><span class="gsc_g_al">625</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:7px;height:153px;z-index:4"><span class="gsc_g_al">672</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:20px;height:140px;z-index:3"><span class="gsc_g_al">616</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:8px;height:152px;z-index:2"><span class="gsc_g_al">669</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:19px;height:141px;z-index:1"><span class="gsc_g_al">619</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=9lxA1jEAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3d9lxA1jEAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>40 articles</span></div><div class="gsc_rsb_m_na"><div class="gs_gray">0 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:0%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span class="gs_gray">not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_co" role="region" aria-labelledby="gsc_prf_t-ath"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Co-authors</span></h3><ul class="gsc_rsb_a"><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-UIrmjcIAAAAJ-img{width:24px;height:32px;}.gs_el_ta #gsc_rsb-UIrmjcIAAAAJ-img,.gs_el_ph #gsc_rsb-UIrmjcIAAAAJ-img{width:42px;height:56px;}</style><span id="gsc_rsb-UIrmjcIAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Robert Coleman" sizes="(max-width:981px) 42px,24px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=UIrmjcIAAAAJ&amp;citpid=2" id="gsc_rsb-UIrmjcIAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=UIrmjcIAAAAJ&amp;citpid=2 24w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=UIrmjcIAAAAJ&amp;citpid=2 42w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=UIrmjcIAAAAJ&amp;citpid=2 96w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=UIrmjcIAAAAJ&amp;hl=en">Robert Coleman</a><span class="gsc_rsb_a_ext">University of Sheffield</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at sheffield.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-jG2-1ysAAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-jG2-1ysAAAAJ-img,.gs_el_ph #gsc_rsb-jG2-1ysAAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-jG2-1ysAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Peter I Croucher" sizes="(max-width:981px) 56px,32px" src="/citations/images/avatar_scholar_56.png" id="gsc_rsb-jG2-1ysAAAAJ-img" class="gs_pp_df" srcset="/citations/images/avatar_scholar_32.png 32w,/citations/images/avatar_scholar_56.png 56w,/citations/images/avatar_scholar_128.png 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=jG2-1ysAAAAJ&amp;hl=en">Peter I Croucher</a><span class="gsc_rsb_a_ext">Garvan Institute</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at garvan.org.au</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-tNHG-gQAAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-tNHG-gQAAAAJ-img,.gs_el_ph #gsc_rsb-tNHG-gQAAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-tNHG-gQAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Per O. Seglen" sizes="(max-width:981px) 56px,32px" src="/citations/images/avatar_scholar_56.png" id="gsc_rsb-tNHG-gQAAAAJ-img" class="gs_pp_df" srcset="/citations/images/avatar_scholar_32.png 32w,/citations/images/avatar_scholar_56.png 56w,/citations/images/avatar_scholar_128.png 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=tNHG-gQAAAAJ&amp;hl=en">Per O. Seglen</a><span class="gsc_rsb_a_ext">Professor emeritus</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at ncmm.uio.no</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-p1Ay-osAAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-p1Ay-osAAAAJ-img,.gs_el_ph #gsc_rsb-p1Ay-osAAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-p1Ay-osAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Dr Neil Cross" sizes="(max-width:981px) 56px,32px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=p1Ay-osAAAAJ&amp;citpid=3" id="gsc_rsb-p1Ay-osAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=p1Ay-osAAAAJ&amp;citpid=3 32w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=p1Ay-osAAAAJ&amp;citpid=3 56w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=p1Ay-osAAAAJ&amp;citpid=3 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=p1Ay-osAAAAJ&amp;hl=en">Dr Neil Cross</a><span class="gsc_rsb_a_ext">Reader in Cancer Biology, Sheffield Hallam University</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at shu.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-bBtTl24AAAAJ-img{width:27px;height:32px;}.gs_el_ta #gsc_rsb-bBtTl24AAAAJ-img,.gs_el_ph #gsc_rsb-bBtTl24AAAAJ-img{width:47px;height:56px;}</style><span id="gsc_rsb-bBtTl24AAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Valerie Speirs" sizes="(max-width:981px) 47px,27px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=bBtTl24AAAAJ&amp;citpid=2" id="gsc_rsb-bBtTl24AAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=bBtTl24AAAAJ&amp;citpid=2 27w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=bBtTl24AAAAJ&amp;citpid=2 47w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=bBtTl24AAAAJ&amp;citpid=2 106w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=bBtTl24AAAAJ&amp;hl=en">Valerie Speirs</a><span class="gsc_rsb_a_ext">Professor of Molecular Oncology, Aberdeen University</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at abdn.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-H2KM-nYAAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-H2KM-nYAAAAJ-img,.gs_el_ph #gsc_rsb-H2KM-nYAAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-H2KM-nYAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Karen Blyth" sizes="(max-width:981px) 56px,32px" src="/citations/images/avatar_scholar_56.png" id="gsc_rsb-H2KM-nYAAAAJ-img" class="gs_pp_df" srcset="/citations/images/avatar_scholar_32.png 32w,/citations/images/avatar_scholar_56.png 56w,/citations/images/avatar_scholar_128.png 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=H2KM-nYAAAAJ&amp;hl=en">Karen Blyth</a><span class="gsc_rsb_a_ext">CRUK Beatson Institute</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at beatson.gla.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-ZL2owqcAAAAJ-img{width:21px;height:32px;}.gs_el_ta #gsc_rsb-ZL2owqcAAAAJ-img,.gs_el_ph #gsc_rsb-ZL2owqcAAAAJ-img{width:37px;height:56px;}</style><span id="gsc_rsb-ZL2owqcAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Philippe Clezardin" sizes="(max-width:981px) 37px,21px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1" id="gsc_rsb-ZL2owqcAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1 21w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1 37w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1 85w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=ZL2owqcAAAAJ&amp;hl=en">Philippe Clezardin</a><span class="gsc_rsb_a_ext">Professor in Bone Oncology</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at sheffield.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-c1TCb18AAAAJ-img{width:21px;height:32px;}.gs_el_ta #gsc_rsb-c1TCb18AAAAJ-img,.gs_el_ph #gsc_rsb-c1TCb18AAAAJ-img{width:37px;height:56px;}</style><span id="gsc_rsb-c1TCb18AAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="daniele santini" sizes="(max-width:981px) 37px,21px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=c1TCb18AAAAJ&amp;citpid=2" id="gsc_rsb-c1TCb18AAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=c1TCb18AAAAJ&amp;citpid=2 21w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=c1TCb18AAAAJ&amp;citpid=2 37w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=c1TCb18AAAAJ&amp;citpid=2 85w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=c1TCb18AAAAJ&amp;hl=en">daniele santini</a><span class="gsc_rsb_a_ext">professor in general pathology</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at unicampus.it</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-W9T5vVQAAAAJ-img{width:25px;height:32px;}.gs_el_ta #gsc_rsb-W9T5vVQAAAAJ-img,.gs_el_ph #gsc_rsb-W9T5vVQAAAAJ-img{width:44px;height:56px;}</style><span id="gsc_rsb-W9T5vVQAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Monica Fengsrud Brinchmann" sizes="(max-width:981px) 44px,25px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=W9T5vVQAAAAJ&amp;citpid=3" id="gsc_rsb-W9T5vVQAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=W9T5vVQAAAAJ&amp;citpid=3 25w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=W9T5vVQAAAAJ&amp;citpid=3 44w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=W9T5vVQAAAAJ&amp;citpid=3 100w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=W9T5vVQAAAAJ&amp;hl=en">Monica Fengsrud Brinchmann</a><span class="gsc_rsb_a_ext">Professor in Molecular Cell Biology, Nord University, Bodø, Norway</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at nord.no</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-dtAoZpIAAAAJ-img{width:21px;height:32px;}.gs_el_ta #gsc_rsb-dtAoZpIAAAAJ-img,.gs_el_ph #gsc_rsb-dtAoZpIAAAAJ-img{width:37px;height:56px;}</style><span id="gsc_rsb-dtAoZpIAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Jukka Mönkkönen" sizes="(max-width:981px) 37px,21px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=dtAoZpIAAAAJ&amp;citpid=2" id="gsc_rsb-dtAoZpIAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=dtAoZpIAAAAJ&amp;citpid=2 21w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=dtAoZpIAAAAJ&amp;citpid=2 37w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=dtAoZpIAAAAJ&amp;citpid=2 85w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=dtAoZpIAAAAJ&amp;hl=en">Jukka Mönkkönen</a><span class="gsc_rsb_a_ext">Biofarmasian professori, Itä-Suomen yliopisto</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at uef.fi</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li></ul></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:76px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:47pt;height:80pt;}}</style><img alt="Ingunn Holen" sizes="print 47px,76px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=9lxA1jEAAAAJ&amp;citpid=2" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=9lxA1jEAAAAJ&amp;citpid=2 76w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=9lxA1jEAAAAJ&amp;citpid=2 152w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Ingunn Holen</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=9829198446306616343" class="gsc_prf_ila">University of Sheffield</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at sheffield.ac.uk - <a href="http://www.sheffield.ac.uk/oncology-metabolism/staff/holen" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:breast_cancer" class="gsc_prf_inta gs_ibl">Breast Cancer</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:bone_metastases" class="gsc_prf_inta gs_ibl">bone metastases</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:bone_biology" class="gsc_prf_inta gs_ibl">bone biology</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a><a id="gsc_prf_t-ath" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_co">Co-authors</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYVNfK8R0lnIHvWSSUwFu1VBKlpVpDf0F"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=9lxA1jEAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma</a><div class="gs_gray">PI Croucher, CM Shipman, J Lippitt, M Perry, K Asosingh, A Hijzen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 98 (13), 3534-3540<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17509071992162250539" class="gsc_a_ac gs_ibl">426</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer</a><div class="gs_gray">SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...</div><div class="gs_gray">Breast Cancer Research 15 (5), 1-37<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16848345574059897435" class="gsc_a_ac gs_ibl">413</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells</a><div class="gs_gray">I Holen, PI Croucher, FC Hamdy, CL Eaton</div><div class="gs_gray">Cancer research 62 (6), 1619-1623<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4462427629200180448" class="gsc_a_ac gs_ibl">335</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Tumour macrophages as potential targets of bisphosphonates</a><div class="gs_gray">TL Rogers, I Holen</div><div class="gs_gray">Journal of translational medicine 9 (1), 1-17<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8335367348385750347" class="gsc_a_ac gs_ibl">280</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Exploring the anti-tumour activity of bisphosphonates in early breast cancer</a><div class="gs_gray">MC Winter, I Holen, RE Coleman</div><div class="gs_gray">Cancer treatment reviews 34 (5), 453-475<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=195425793210744451" class="gsc_a_ac gs_ibl">277</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis</a><div class="gs_gray">MT Haider, I Holen, TN Dear, K Hunter, HK Brown</div><div class="gs_gray">Bone 66, 240-250<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13758983681876255758" class="gsc_a_ac gs_ibl">262</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:8AbLer7MMksC" class="gsc_a_at">Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway</a><div class="gs_gray">M Coscia, E Quaglino, M Iezzi, C Curcio, F Pantaleoni, C Riganti, I Holen, ...</div><div class="gs_gray">Journal of cellular and molecular medicine 14 (12), 2803-2815<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16471771490778673076" class="gsc_a_ac gs_ibl">252</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer</a><div class="gs_gray">PD Ottewell, H Mönkkönen, M Jones, DV Lefley, RE Coleman, I Holen</div><div class="gs_gray">Journal of the National Cancer Institute 100 (16), 1167-1178<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6259955740659229791" class="gsc_a_ac gs_ibl">251</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:geHnlv5EZngC" class="gsc_a_at">Sequence‐and schedule‐dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells</a><div class="gs_gray">HL Neville‐Webbe, A Rostami‐Hodjegan, CA Evans, RE Coleman, ...</div><div class="gs_gray">International journal of cancer 113 (3), 364-371<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9761376852713868828" class="gsc_a_ac gs_ibl">186</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Multidrug resistance in breast cancer: from in vitro models to clinical studies</a><div class="gs_gray">NS Wind, I Holen</div><div class="gs_gray">International journal of breast cancer 2011<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15673219560301987783" class="gsc_a_ac gs_ibl">182</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Dependence of hepatocytic autophagy on intracellularly sequestered calcium.</a><div class="gs_gray">PB Gordon, I Holen, M Fosse, JS Røtnes, PO Seglen</div><div class="gs_gray">Journal of Biological Chemistry 268 (35), 26107-26112<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10138521044349284254" class="gsc_a_ac gs_ibl">175</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Optimizing the yield and utility of circulating cell-free DNA from plasma and serum</a><div class="gs_gray">X Xue, MD Teare, I Holen, YM Zhu, PJ Woll</div><div class="gs_gray">Clinica chimica acta 404 (2), 100-104<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13464142007964809496" class="gsc_a_ac gs_ibl">165</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis</a><div class="gs_gray">HL Neville-Webbe, NA Cross, CL Eaton, R Nyambo, CA Evans, ...</div><div class="gs_gray">Breast cancer research and treatment 86 (3), 271-282<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11983944298312516243" class="gsc_a_ac gs_ibl">142</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel</a><div class="gs_gray">P Hadji, RE Coleman, C Wilson, TJ Powles, P Clézardin, M Aapro, ...</div><div class="gs_gray">Annals of Oncology 27 (3), 379-390<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5605155776630200448" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Zoledronic acid has differential antitumor activity in the pre-and postmenopausal bone microenvironment in vivo</a><div class="gs_gray">PD Ottewell, N Wang, HK Brown, KJ Reeves, CA Fowles, PI Croucher, ...</div><div class="gs_gray">Clinical Cancer Research 20 (11), 2922-2932<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1870818133054231724" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Expression and activity of ADAMTS‐5 in synovium</a><div class="gs_gray">MN Vankemmelbeke, I Holen, AG Wilson, MZ Ilic, CJ Handley, GS Kelner, ...</div><div class="gs_gray">European Journal of Biochemistry 268 (5), 1259-1268<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14248458145855196219" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Role of osteoprotegerin (OPG) in cancer</a><div class="gs_gray">I Holen, CM Shipman</div><div class="gs_gray">Clinical science 110 (3), 279-291<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3377155602527915099" class="gsc_a_ac gs_ibl">139</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo–a role in tumour cell survival?</a><div class="gs_gray">I Holen, SS Cross, HL Neville-Webbe, NA Cross, SP Balasubramanian, ...</div><div class="gs_gray">Breast cancer research and treatment 92 (3), 207-215<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5677367709761591025" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">The detection of circulating breast cancer cells in blood</a><div class="gs_gray">AM Gilbey, D Burnett, RE Coleman, I Holen</div><div class="gs_gray">Journal of clinical pathology 57 (9), 903-911<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9333482449089559572" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;citation_for_view=9lxA1jEAAAAJ:D_sINldO8mEC" class="gsc_a_at">The anti-tumour activity of bisphosphonates</a><div class="gs_gray">HL Neville-Webbe, I Holen, RE Coleman</div><div class="gs_gray">Cancer treatment reviews 28 (6), 305-319<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16187712862677432007" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Pathophysiological roles of osteoprotegerin (OPG)</a><div class="gs_gray">P Reid, I Holen</div><div class="gs_gray">European journal of cell biology 88 (1), 1-17<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8580448571489127004" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Evaluation of the current knowledge limitations in breast cancer research: a gap analysis</a><div class="gs_gray">A Thompson, K Brennan, A Cox, J Gee, D Harcourt, A Harris, M Harvie, ...</div><div class="gs_gray">Breast Cancer Research 10 (2), 1-25<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=675523032075278655" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Disruption of the cytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acid</a><div class="gs_gray">H Blankson, I Holen, PO Seglen</div><div class="gs_gray">Experimental cell research 218 (2), 522-530<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12143026880317824143" class="gsc_a_ac gs_ibl">128</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:olpn-zPbct0C" class="gsc_a_at">Metastasis and bone loss: advancing treatment and prevention</a><div class="gs_gray">RE Coleman, A Lipton, GD Roodman, TA Guise, BF Boyce, AM Brufsky, ...</div><div class="gs_gray">Cancer treatment reviews 36 (8), 615-620<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16211862204007151698" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:eflP2zaiRacC" class="gsc_a_at">Non-selective autophagy.</a><div class="gs_gray">PO Seglen, PB Gordon, I Holen</div><div class="gs_gray">Seminars in cell biology 1 (6), 441-448<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4360263527715657817" class="gsc_a_ac gs_ibl">124</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">In vivo models in breast cancer research: progress, challenges and future directions</a><div class="gs_gray">I Holen, V Speirs, B Morrissey, K Blyth</div><div class="gs_gray">Disease models &amp; mechanisms 10 (4), 359-371<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15029255622139888506" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">IL-1 drives breast cancer growth and bone metastasis in vivo</a><div class="gs_gray">I Holen, DV Lefley, SE Francis, S Rennicks, S Bradbury, RE Coleman, ...</div><div class="gs_gray">Oncotarget 7 (46), 75571<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16870107944820355734" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro</a><div class="gs_gray">HL Neville-Webbe, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">Tumor Biology 27 (2), 92-103<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9738891377107792225" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?</a><div class="gs_gray">SS Cross, Z Yang, NJ Brown, SP Balasubramanian, CA Evans, ...</div><div class="gs_gray">International journal of cancer 118 (8), 1901-1908<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14473632925890457259" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrity</a><div class="gs_gray">I Holen, PB Gordon, PO Seglen</div><div class="gs_gray">Biochemical Journal 284 (3), 633-636<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6664723232616190090" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Structural aspects of autophagy</a><div class="gs_gray">PO Seglen, TO Berg, H Blankson, M Fengsrud, I Holen, PE Strømhaug</div><div class="gs_gray">Intracellular protein catabolism, 103-111<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15485179211747667822" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Bisphosphonates as treatment of bone metastases</a><div class="gs_gray">I Holen, R E Coleman</div><div class="gs_gray">Current pharmaceutical design 16 (11), 1262-1271<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16876604229400901073" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:WZBGuue-350C" class="gsc_a_at">Bone metastases</a><div class="gs_gray">RE Coleman, J Brown, I Holen</div><div class="gs_gray">Abeloff's Clinical Oncology, 809-830. e3<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6739412810352577094" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Prostate cancer cells preferentially home to osteoblast‐rich areas in the early stages of bone metastasis: evidence from in vivo models</a><div class="gs_gray">N Wang, FE Docherty, HK Brown, KJ Reeves, ACM Fowles, PD Ottewell, ...</div><div class="gs_gray">Journal of Bone and Mineral Research 29 (12), 2688-2696<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6062500311519679825" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:5ugPr518TE4C" class="gsc_a_at">Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo</a><div class="gs_gray">PD Ottewell, B Deux, H Mönkkönen, S Cross, RE Coleman, P Clezardin, ...</div><div class="gs_gray">Clinical Cancer Research 14 (14), 4658-4666<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13457635263793836769" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Inhibition of hepatocytic autophagy by okadaic acid and other protein phosphatase inhibitors</a><div class="gs_gray">I HOLEN, PB GORDON, PO SEGLEN</div><div class="gs_gray">European journal of biochemistry 215 (1), 113-122<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7528577739460250563" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours</a><div class="gs_gray">C Van Poznak, SS Cross, M Saggese, C Hudis, KS Panageas, L Norton, ...</div><div class="gs_gray">Journal of clinical pathology 59 (1), 56-63<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13647168233141024024" class="gsc_a_ac gs_ibl">98</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:HE397vMXCloC" class="gsc_a_at">Protection by Naringin and Some Other Flavonoids of Hepatocytic Autophagy and Endocytosis against Inhibition by Okadaic Acid (∗)</a><div class="gs_gray">PB Gordon, I Holen, PO Seglen</div><div class="gs_gray">Journal of Biological Chemistry 270 (11), 5830-5838<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9912365026784900102" class="gsc_a_ac gs_ibl">97</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies</a><div class="gs_gray">PD Ottewell, RE Coleman, I Holen</div><div class="gs_gray">Breast cancer research and treatment 96 (2), 101-113<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13120407267672768692" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone</a><div class="gs_gray">PD Ottewell, JK Woodward, DV Lefley, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">Molecular cancer therapeutics 8 (10), 2821-2832<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8990282911812255553" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model</a><div class="gs_gray">PD Ottewell, DV Lefley, SS Cross, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">International journal of cancer 126 (2), 522-532<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=501319973215083632" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone</a><div class="gs_gray">PD Ottewell, N Wang, J Meek, CA Fowles, PI Croucher, CL Eaton, I Holen</div><div class="gs_gray">Endocrine-related cancer 21 (5), 769-781<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7635451997940541779" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth</a><div class="gs_gray">H Mönkkönen, J Kuokkanen, I Holen, A Evans, DV Lefley, M Jauhiainen, ...</div><div class="gs_gray">Anti-cancer drugs 19 (4), 391-399<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12516607713844930385" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Mechanisms of disease: preclinical reports of antineoplastic synergistic action of bisphosphonates</a><div class="gs_gray">D Santini, M Caraglia, B Vincenzi, I Holen, S Scarpa, A Budillon, G Tonini</div><div class="gs_gray">Nature Clinical Practice Oncology 3 (6), 325-338<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12178290706528409515" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Zoledronic acid-induced IPP/ApppI production in vivo</a><div class="gs_gray">H Mönkkönen, PD Ottewell, J Kuokkanen, J Mönkkönen, S Auriola, ...</div><div class="gs_gray">Life sciences 81 (13), 1066-1070<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13822968005569273011" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line</a><div class="gs_gray">F Nutter, I Holen, HK Brown, SS Cross, CA Evans, M Walker, RE Coleman, ...</div><div class="gs_gray">Endocrine-related cancer 21 (2), 327-341<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3229186027295005950" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations&nbsp;…</a><div class="gs_gray">SS Cross, RF Harrison, SP Balasubramanian, JM Lippitt, CA Evans, ...</div><div class="gs_gray">Journal of clinical pathology 59 (7), 716-720<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2948357290361932450" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer</a><div class="gs_gray">CL Eaton, JM Wells, I Holen, PI Croucher, FC Hamdy</div><div class="gs_gray">The Prostate 59 (3), 304-310<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2445018447871863754" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">CAPG and GIPC1: breast cancer biomarkers for bone metastasis development and treatment</a><div class="gs_gray">JA Westbrook, DA Cairns, J Peng, V Speirs, AM Hanby, I Holen, SL Wood, ...</div><div class="gs_gray">Journal of the National Cancer Institute 108 (4), djv360<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3223410144596469565" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Targeting RANKL in metastasis</a><div class="gs_gray">WC Dougall, I Holen, EG Suárez</div><div class="gs_gray">BoneKEy reports 3<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1536350249065912612" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:_B80troHkn4C" class="gsc_a_at">Human bone marrow stromal cells protect prostate cancer cells from TRAIL‐induced apoptosis</a><div class="gs_gray">R Nyambo, N Cross, J Lippitt, I Holen, G Bryden, FC Hamdy, CL Eaton</div><div class="gs_gray">Journal of Bone and Mineral Research 19 (10), 1712-1721<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3631495821043259758" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Anti-tumour activity of bisphosphonates in preclinical models of breast cancer</a><div class="gs_gray">I Holen, RE Coleman</div><div class="gs_gray">Breast cancer research 12 (6), 1-13<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6514007727397137207" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer</a><div class="gs_gray">JKL Woodward, I Holen, RE Coleman, DJ Buttle</div><div class="gs_gray">Bone 41 (6), 912-927<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2320996946304679581" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment</a><div class="gs_gray">C Tulotta, DV Lefley, K Freeman, WM Gregory, AM Hanby, PR Heath, ...</div><div class="gs_gray">Clinical Cancer Research 25 (9), 2769-2782<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15115833962705079656" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro</a><div class="gs_gray">JKL Woodward, HL Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">Anti-cancer drugs 16 (8), 845-854<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5936748460122116060" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Role of cAMP in the regulation of hepatocytic autophagy</a><div class="gs_gray">I Holen, PB Gordon, PE Strømhaug, PO Seglen</div><div class="gs_gray">European journal of biochemistry 236 (1), 163-170<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3818374686118010098" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:5awf1xo2G04C" class="gsc_a_at">Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours</a><div class="gs_gray">D Santini, B Vincenzi, RA Hannon, JE Brown, G Dicuonzo, S Angeletti, ...</div><div class="gs_gray">Oncology reports 15 (5), 1351-1357<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16805633357384437020" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Raman spectroscopic analysis differentiates between breast cancer cell lines</a><div class="gs_gray">ACS Talari, CA Evans, I Holen, RE Coleman, IU Rehman</div><div class="gs_gray">Journal of Raman Spectroscopy 46 (5), 421-427<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2820457179697250067" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells <i>in vitro</i>: evidence of synergistic interaction</a><div class="gs_gray">HL Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">British journal of cancer 102 (6), 1010-1017<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12584400063903467841" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">The metastatic microenvironment of breast cancer: clinical implications</a><div class="gs_gray">RE Coleman, W Gregory, H Marshall, C Wilson, I Holen</div><div class="gs_gray">The Breast 22, S50-S56<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17752462893314075774" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Inhibition of Autophagy and Multiple Steps in Asialoglycoprotein Endocytosis by Inhibitors of Tyrosine Protein Kinases (Tyrphostins)(∗)</a><div class="gs_gray">I Holen, PB Gordon, M Fengsrud, TO Berg, PO Seglen</div><div class="gs_gray">Journal of Biological Chemistry 270 (21), 12823-12831<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6905780418279117751" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:e_rmSamDkqQC" class="gsc_a_at">The breast tumor microenvironment: role in cancer development, progression and response to therapy</a><div class="gs_gray">S Mittal, NJ Brown, I Holen</div><div class="gs_gray">Expert review of molecular diagnostics 18 (3), 227-243<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6103515116120506941" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonates</a><div class="gs_gray">C Wilson, I Holen, RE Coleman</div><div class="gs_gray">Cancer treatment reviews 38 (7), 877-889<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4009388200185408167" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:W5xh706n7nkC" class="gsc_a_at">Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo</a><div class="gs_gray">I Holen, J Whitworth, F Nutter, A Evans, HK Brown, DV Lefley, I Barbaric, ...</div><div class="gs_gray">Breast Cancer Research 14 (3), 1-14<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1342759404185013821" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity</a><div class="gs_gray">M David, I Machuca-Gayet, J Kikuta, P Ottewell, F Mima, R Leblanc, ...</div><div class="gs_gray">Journal of Biological Chemistry 289 (10), 6551-6564<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8413439824665546204" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">OPG‐Fc inhibits ovariectomy‐induced growth of disseminated breast cancer cells in bone</a><div class="gs_gray">PD Ottewell, N Wang, HK Brown, CA Fowles, PI Croucher, CL Eaton, ...</div><div class="gs_gray">International journal of cancer 137 (4), 968-977<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13918722312369018314" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Anti-tumour effects of bisphosphonates-what have we learned from in vivo models?</a><div class="gs_gray">HK Brown, I Holen</div><div class="gs_gray">Current cancer drug targets 9 (7), 807-823<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2039374423321762241" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:EkHepimYqZsC" class="gsc_a_at">Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer</a><div class="gs_gray">N Wang, F Docherty, HK Brown, K Reeves, A Fowles, M Lawson, ...</div><div class="gs_gray">The FASEB Journal 29 (8), 3141-3150<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14185768887856734406" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Evidence of a role for a non‐matrix‐type metalloproteinase activity in the shedding of syndecan‐1 from human myeloma cells</a><div class="gs_gray">I Holen, NL Drury, PG Hargreaves, PI Croucher</div><div class="gs_gray">British journal of haematology 114 (2), 414-421<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1256329134339308277" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel?</a><div class="gs_gray">M Michailidou, HK Brown, DV Lefley, A Evans, SS Cross, RE Coleman, ...</div><div class="gs_gray">Journal of vascular research 47 (6), 481-493<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2327858453662697071" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact</a><div class="gs_gray">PE Reid, NJ Brown, I Holen</div><div class="gs_gray">Molecular cancer 8 (1), 1-10<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3551891160452503423" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:epqYDVWIO7EC" class="gsc_a_at">The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer</a><div class="gs_gray">N Wang, KJ Reeves, HK Brown, ACM Fowles, FE Docherty, PD Ottewell, ...</div><div class="gs_gray">Journal of experimental &amp; clinical cancer research 34 (1), 1-12<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14871538862030637439" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy</a><div class="gs_gray">RD Clyburn, P Reid, CA Evans, DV Lefley, I Holen</div><div class="gs_gray">Cancer chemotherapy and pharmacology 65 (5), 969-978<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1221731015468900626" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions</a><div class="gs_gray">I Holen, F Nutter, JM Wilkinson, CA Evans, P Avgoustou, PD Ottewell</div><div class="gs_gray">Clinical &amp; experimental metastasis 32 (7), 689-702<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7284319259487712102" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Hepatocytic autophagy.</a><div class="gs_gray">PO Seglen, PB Gordon, I Holen, H Høyvik</div><div class="gs_gray">Biomedica biochimica acta 50 (4-6), 373-381<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15460890148773309403" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Bovine joint capsule and fibroblasts derived from joint capsule express aggrecanase activity</a><div class="gs_gray">MZ Ilic, MN Vankemmelbeke, I Holen, DJ Buttle, HC Robinson, ...</div><div class="gs_gray">Matrix Biology 19 (3), 257-265<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6984557134609328289" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo</a><div class="gs_gray">HK Brown, PD Ottewell, CA Evans, I Holen</div><div class="gs_gray">Clinical &amp; experimental metastasis 29 (8), 927-938<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4806410169992227712" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Macrophages as potential targets for zoledronic acid outside the skeleton—evidence from in vitro and in vivo models</a><div class="gs_gray">TL Rogers, N Wind, R Hughes, F Nutter, HK Brown, I Vasiliadou, ...</div><div class="gs_gray">Cellular oncology 36 (6), 505-514<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1021905135889499777" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Molecular alterations that drive breast cancer metastasis to bone</a><div class="gs_gray">PD Ottewell, L O'donnell, I Holen</div><div class="gs_gray">BoneKEy reports 4<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1371118975468230267" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:z_wVstp3MssC" class="gsc_a_at">Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells</a><div class="gs_gray">M Kobayashi‐Sakamoto, E Isogai, I Holen</div><div class="gs_gray">European journal of haematology 85 (1), 26-35<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17241110257062807462" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Effects of Src-kinase inhibition in cancer-induced bone pain</a><div class="gs_gray">M De Felice, D Lambert, I Holen, KJ Escott, D Andrew</div><div class="gs_gray">Molecular pain 12, 1744806916643725<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5496770420169016479" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo</a><div class="gs_gray">I Holen, M Walker, F Nutter, A Fowles, CA Evans, CL Eaton, PD Ottewell</div><div class="gs_gray">Clinical &amp; experimental metastasis 33 (3), 211-224<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18204529309123705415" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:4DMP91E08xMC" class="gsc_a_at">The role of macrophages in bone metastasis</a><div class="gs_gray">I Vasiliadou, I Holen</div><div class="gs_gray">Journal of bone oncology 2 (4), 158-166<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14776584483052512326" class="gsc_a_ac gs_ibl gsc_a_acm" data-eid="9lxA1jEAAAAJ:4DMP91E08xMC" data-eud="9lxA1jEAAAAJ:W7OEmFMy1HYC">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">The role of macrophages in bone metastasis</a><div class="gs_gray">I Vasiliadou, I Holen</div><div class="gs_gray">Journal of bone oncology 2 (4), 158-166<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14776584483052512326" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples</a><div class="gs_gray">TR Cawthorn, E Amir, R Broom, O Freedman, D Gianfelice, D Barth, ...</div><div class="gs_gray">Clinical &amp; experimental metastasis 26 (8), 935<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3976705393108205233" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumor cell invasion</a><div class="gs_gray">JKL Woodward, RE Coleman, I Holen</div><div class="gs_gray">Anti-cancer drugs 16 (1), 11-19<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=523923337807790419" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Bone metastasis: molecular mechanisms implicated in tumour cell dormancy in breast and prostate cancer</a><div class="gs_gray">L Quayle, P D Ottewell, I Holen</div><div class="gs_gray">Current cancer drug targets 15 (6), 469-480<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8412640573444370373" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:rmuvC79q63oC" class="gsc_a_at">The bone metastasis niche in breast cancer: Potential overlap with the haematopoietic stem cell niche in vivo</a><div class="gs_gray">G Allocca, R Hughes, N Wang, HK Brown, PD Ottewell, NJ Brown, I Holen</div><div class="gs_gray">Journal of bone oncology 17, 100244<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8398064071036825002" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo</a><div class="gs_gray">MT Haider, KD Hunter, SP Robinson, TJ Graham, E Corey, TN Dear, ...</div><div class="gs_gray">Bone 81, 581-592<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8084025273974244449" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer—a randomized biomarker pilot study</a><div class="gs_gray">MC Winter, C Wilson, SP Syddall, SS Cross, A Evans, CE Ingram, IJ Jolley, ...</div><div class="gs_gray">Clinical Cancer Research 19 (10), 2755-2765<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15969023340950273534" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice</a><div class="gs_gray">PD Ottewell, HK Brown, M Jones, TL Rogers, SS Cross, NJ Brown, ...</div><div class="gs_gray">Breast cancer research and treatment 133 (2), 523-536<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6714210996606230020" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:evX43VCCuoAC" class="gsc_a_at">The kinetochore protein Cenp‐F is a potential novel target for zoledronic acid in breast cancer cells</a><div class="gs_gray">HK Brown, PD Ottewell, RE Coleman, I Holen</div><div class="gs_gray">Journal of cellular and molecular medicine 15 (3), 501-513<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16598967264868230587" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Inhibition of asialoglycoprotein endocytosis and degradation in rat hepatocytes by protein phosphatase inhibitors</a><div class="gs_gray">I Holen, PB Gordon, PE Strømhaug, TO Berg, M Fengsrud, A Brech, ...</div><div class="gs_gray">Biochemical Journal 311 (1), 317-326<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11185427445825109730" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:35r97b3x0nAC" class="gsc_a_at">Morphological transformation and catalase activity of Syrian hamster embryo cells treated with hepatic peroxisome proliferators, TPA and nickel sulphate</a><div class="gs_gray">S Mikalsen, I Holen, T Sanner</div><div class="gs_gray">Cell biology and toxicology 6 (1), 1-13<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4691792609112493890" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:tYavs44e6CUC" class="gsc_a_at">Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells</a><div class="gs_gray">JM Ubellacker, MT Haider, MJ DeCristo, G Allocca, NJ Brown, DP Silver, ...</div><div class="gs_gray">Breast Cancer Research 19 (1), 1-15<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3170815156571970641" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Tumour cells isolated from patients with multiple myeloma express the critical osteoclastogenic factor, RANKL.</a><div class="gs_gray">CM Shipman, I Holen, JM Lippitt, E Vandenberghe, PI Croucher</div><div class="gs_gray">Blood 96 (11)<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8718293285326843163" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Role of cyclic nucleotides in the control of hepatic autophagy.</a><div class="gs_gray">I Holen, PB Gordon, PO Seglen</div><div class="gs_gray">Biomedica biochimica acta 50 (4-6), 389-392<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1096260526827792157" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Effects of dinitrotoluenes on morphological cell transformation and intercellular communication in Syrian hamster embryo cells</a><div class="gs_gray">I Holen, SO Mikalsen, T Sanner</div><div class="gs_gray">Journal of Toxicology and Environmental Health, Part A Current Issues 29 (1&nbsp;…<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3259658249997539210" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention</a><div class="gs_gray">LA Quayle, PD Ottewell, I Holen</div><div class="gs_gray">Clinical &amp; experimental metastasis 35 (8), 831-846<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15362314396686363931" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=9lxA1jEAAAAJ:vDijr-p_gm4C" class="gsc_a_at">The differential anti-tumour effects of zoledronic acid in breast cancer–evidence for a role of the activin signaling pathway</a><div class="gs_gray">C Wilson, P Ottewell, RE Coleman, I Holen</div><div class="gs_gray">BMC cancer 15 (1), 1-11<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=185956848777593044" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Combined therapies of bone disease with bisphosphonates</a><div class="gs_gray">S P Syddall, P D Ottewell, I Holen</div><div class="gs_gray">Current pharmaceutical design 16 (27), 2988-2997<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8594345678633145297" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Modulating bone marrow hematopoietic lineage potential to prevent bone metastasis in breast cancer</a><div class="gs_gray">JM Ubellacker, N Baryawno, N Severe, MJ DeCristo, J Sceneay, ...</div><div class="gs_gray">Cancer research 78 (18), 5300-5314<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=672810362647222480" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts</a><div class="gs_gray">D Lefley, F Howard, F Arshad, S Bradbury, H Brown, C Tulotta, R Eyre, ...</div><div class="gs_gray">Breast Cancer Research 21 (1), 1-21<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5858004616146551804" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:uWiczbcajpAC" class="gsc_a_at">Imaging the effects of castration on bone turnover and hormone‐independent prostate cancer colonization of bone</a><div class="gs_gray">NA Cross, A Fowles, K Reeves, N Jokonya, K Linton, I Holen, FC Hamdy, ...</div><div class="gs_gray">The Prostate 68 (15), 1707-1714<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8464950945239049437" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:URolC5Kub84C" class="gsc_a_at">Abstract P1-11-01: ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer</a><div class="gs_gray">MC Winter, SP Syddall, SS Cross, A Evans, CE Ingram, IJ Jolley, ...</div><div class="gs_gray">Cancer Research 70 (24 Supplement), P1-11-01-P1-11-01<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16239163823932321754" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:p__nRnzSRKYC" class="gsc_a_at">SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs</a><div class="gs_gray">K Blyth, P Carter, B Morrissey, C Chelala, L Jones, I Holen, V Speirs</div><div class="gs_gray">Breast cancer research and treatment 156 (3), 447-452<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15570827946318533670" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:4MWp96NkSFoC" class="gsc_a_at">A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts</a><div class="gs_gray">HK Brown, PD Ottewell, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">Journal of bone oncology 1 (2), 47-56<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6769171684133356821" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:rO6llkc54NcC" class="gsc_a_at">The sharing experimental animal resources, coordinating holdings (SEARCH) framework: encouraging reduction, replacement, and refinement in animal research</a><div class="gs_gray">B Morrissey, K Blyth, P Carter, C Chelala, L Jones, I Holen, V Speirs</div><div class="gs_gray">PLoS biology 15 (1), e2000719<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5286840599675233356" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Effects of adrenergic agonists and antagonists on autophagic activity in isolated rat liver cells.</a><div class="gs_gray">PB Gordon, I Holen, PO Seglen</div><div class="gs_gray">Biomedica biochimica acta 50 (4-6), 383-387<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4612473277433490289" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:umqufdRvDiIC" class="gsc_a_at">Bone metastasis: Mechanisms, therapies, and biomarkers</a><div class="gs_gray">P Clézardin, R Coleman, M Puppo, P Ottewell, E Bonnelye, F Paycha, ...</div><div class="gs_gray">Physiological Reviews 101 (3), 797-855<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8892344609319622862" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:35N4QoGY0k4C" class="gsc_a_at">The endocrine influence on the bone microenvironment in early breast cancer</a><div class="gs_gray">C Wilson, H Brown, I Holen</div><div class="gs_gray">Endocrine-related cancer 23 (12), R567-R576<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3494462382599945468" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Abstract PD07-08: Zoledronic acid specifically inhibits development of bone metastases in the post-menopausal setting–evidence from an in vivo breast cancer model</a><div class="gs_gray">I Holen, N Wang, KJ Reeves, AM Fowles, PI Croucher, CL Eaton, ...</div><div class="gs_gray">Cancer Research 72 (24 Supplement), PD07-08-PD07-08<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6967988735776554308" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells</a><div class="gs_gray">NA Cross, EA Waterman, N Jokonya, A Fowles, CH Buckle, J Phillips, ...</div><div class="gs_gray">Journal of cellular biochemistry 104 (4), 1452-1464<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16325275243725975335" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: Implications for association studies with human cancers</a><div class="gs_gray">EA Waterman, NA Cross, JM Lippitt, SS Cross, I Rehman, I Holen, ...</div><div class="gs_gray">International journal of cancer 121 (9), 1958-1966<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1486395233208785309" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo</a><div class="gs_gray">PD Ottewell, M Jones, RE Coleman, I Holen</div><div class="gs_gray">Breast Cancer Research 8 (2), 1-1<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2036878594788914312" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:foquWX3nUaYC" class="gsc_a_at">Parathyroid Hormone (PTH) increases skeletal tumour growth and alters tumour distribution in an in vivo model of breast cancer</a><div class="gs_gray">HK Brown, G Allocca, PD Ottewell, N Wang, NJ Brown, PI Croucher, ...</div><div class="gs_gray">International journal of molecular sciences 19 (10), 2920<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13074360036542052243" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:hC7cP41nSMkC" class="gsc_a_at">The bone microenvironment-multiple players involved in cancer progression</a><div class="gs_gray">I Holen</div><div class="gs_gray">Journal of bone oncology 5 (3), 87<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11351064487064830238" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:EYYDruWGBe4C" class="gsc_a_at">SEARCHBreast Workshop Proceedings: 3D modelling of breast cancer</a><div class="gs_gray">B Morrissey, K Blyth, P Carter, C Chelala, I Holen, L Jones, V Speirs</div><div class="gs_gray">Alternatives to Laboratory Animals 43 (6), 367-375<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=201987068907946896" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:hMsQuOkrut0C" class="gsc_a_at">ANZAC: a neoadjuvant biomarker study exploring the anti-tumour activity of the AdditioN of Zoledronic Acid to Chemotherapy in breast cancer</a><div class="gs_gray">MC Winter, SS Cross, CE Ingram, IJ Jolley, I Holen, MQ Hatton, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 20, 55-55<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4980404846917785564" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Understanding drug-sequence-dependent synergistic induction of apoptosis by zoledronic acid (ZOL) and doxorubicin (DOX) in breast cancer</a><div class="gs_gray">HL Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S28-S28<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4190582839064107948" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Nonosseous effects of osteoprotegerin</a><div class="gs_gray">P Croucher, I Holen, C Eaton</div><div class="gs_gray">Cancer Treatment Reviews 31, S14-S15<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6072815651327385941" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:FAceZFleit8C" class="gsc_a_at">A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells</a><div class="gs_gray">R Ran, H Harrison, NS Ariffin, R Ayub, HJ Pegg, W Deng, A Mastro, ...</div><div class="gs_gray">Oncogene 39 (12), 2624-2637<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14316814471455543348" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Animal Models</a><div class="gs_gray">GT JONES, J Ranger, J Ursini-Siegel, M Krummel, WJ Muller, PC Blyth, ...</div><div class="gs_gray">Medicographia 30 (2), 154-156<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11659487123086758395" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Mechanical heterogeneity in the bone microenvironment as characterized by atomic force microscopy</a><div class="gs_gray">X Chen, R Hughes, N Mullin, RJ Hawkins, I Holen, NJ Brown, JK Hobbs</div><div class="gs_gray">Biophysical Journal 119 (3), 502-513<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10960213094647570946" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Combinations of bisphosphonates and classical anticancer drugs: a preclinical perspective</a><div class="gs_gray">M Michailidou, I Holen</div><div class="gs_gray">Prevention of Bone Metastases, 145-169<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=573043121872033617" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">In vivo models used in studies of bone metastases</a><div class="gs_gray">I Holen, MA Lawson</div><div class="gs_gray">Bone Cancer, 347-363<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2642207829154718912" class="gsc_a_ac gs_ibl gsc_a_acm" data-eid="9lxA1jEAAAAJ:cFHS6HbyZ2cC" data-eud="9lxA1jEAAAAJ:NaGl4SEjCO4C">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">In vivo models used in studies of bone metastases</a><div class="gs_gray">I Holen, MA Lawson</div><div class="gs_gray">Bone Cancer, 347-363<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2642207829154718912" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer.</a><div class="gs_gray">PD Ottewell, DV Lefley, RE Coleman, I Holen</div><div class="gs_gray">Cancer Research 69 (2 Supplement), 2151<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1493454659499075624" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:86PQX7AUzd4C" class="gsc_a_at">The effects of combined treatment using paclitaxel and zoledronic acid on tumour cells and endothelial cells in vitro</a><div class="gs_gray">M Michailidou, HL Neville-Webbe, JK Woodward, DV Lefley</div><div class="gs_gray">Hematology Meeting Reports (formerly Haematologica Reports) 2 (3)<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6641295579837306095" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Zoledronic acid (ZOL) in combination with doxorubicin (DOX) has synergistic effects on apoptosis of breast cancer cells (BCCs) in vitro</a><div class="gs_gray">HL Neville-Webbe, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19 (9), 1598-1598<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16573804058014696533" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">CDK4/6 inhibitors in breast cancer – from <i>in&nbsp;vitro</i> models to clinical trials</a><div class="gs_gray">L Saleh, C Wilson, I Holen</div><div class="gs_gray">Acta Oncologica 59 (2), 219-232<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7941932640476538547" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid</a><div class="gs_gray">R Hughes, X Chen, KD Hunter, JK Hobbs, I Holen, NJ Brown</div><div class="gs_gray">The FASEB Journal 33 (11), 12768-12779<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3257433751130099532" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:mB3voiENLucC" class="gsc_a_at">SEARCHBreast: a new online resource to make surplus material from in vivo models of breast cancer visible and accessible to researchers</a><div class="gs_gray">B Morrissey, K Blyth, P Carter, C Chelala, L Jones, I Holen, V Speirs</div><div class="gs_gray">Breast Cancer Research 18 (1), 1-2<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11689638279076180570" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Pharmaceutical Uses of Bisphosphonates</a><div class="gs_gray">R Coleman, I Holen, H Neville-Webbe, C Evans</div><div class="gs_gray">US Patent App. 10/578,290<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14971486169094465504" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Bisphosphonates act by inhibiting protein prenylation.</a><div class="gs_gray">SP Luckman, DE Hughes, KM Chilton, FP Coxon, I Holen, RGG Russell, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 12, T372-T372<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5713697210133914240" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Autophagic-endocytic interactions in hepatocytes</a><div class="gs_gray">PO Seglen, PB Gordon, I Holen, H Høyvik, AL Kovács, PE Strømhaug, ...</div><div class="gs_gray">Endocytosis, 247-254<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11428970211392158586" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Osteoblast-Derived Paracrine and Juxtacrine Signals Protect Disseminated Breast Cancer Cells from Stress</a><div class="gs_gray">R Hughes, X Chen, N Cowley, PD Ottewell, RJ Hawkins, KD Hunter, ...</div><div class="gs_gray">Cancers 13 (6), 1366<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11643588279137363487" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Abstract P1-05-01: Breast cancer cell-derived IL-1B drives metastasis and colonisation of the bone microenvironment</a><div class="gs_gray">PD Ottewell, DV Lefley, K Freeman, WM Gregory, AM Hanby, ...</div><div class="gs_gray">Cancer Research 79 (4 Supplement), P1-05-01-P1-05-01<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=556104497818034191" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:r0BpntZqJG4C" class="gsc_a_at">The role of the Microenvironment in Bone Metastasis JBO 2016</a><div class="gs_gray">I Holen</div><div class="gs_gray">Journal of Bone Oncology 5 (3), VV<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17063740385114825486" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Effects of the female hormone inhibin-A in vivo: potential contribution to the antitumour effect of Zoledronic acid</a><div class="gs_gray">C Wilson, F Nutter, H Brown, R Coleman, I Holen</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9503196186324790866" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">The interaction between menopausal status and zoledronic acid can differentially affect serum levels of the TGF beta superfamily.</a><div class="gs_gray">C Wilson, MC Winter, I Holen, JV Freeman, AC Evans, RE Coleman</div><div class="gs_gray">CANCER RESEARCH 72<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6975883547590091738" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Exploring the anti-angiogenic potential of zoledronic acid in combination with neoadjuvant chemotherapy in invasive breast cancer</a><div class="gs_gray">MC Winter, A Evans, I Holen, RE Coleman</div><div class="gs_gray">Bone 47, S310-S310<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11627580728192850196" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid</a><div class="gs_gray">PD Ottewell, DV Lefley, RE Coleman, I Holen</div><div class="gs_gray">Breast Cancer Research 10 (2), 1-2<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5587527365066661698" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">P1. Breast cancer cells cause a reduction in osteoblast number–An early event in the development of osteolytic bone lesions</a><div class="gs_gray">P Ottewell, P Croucher, I Holen</div><div class="gs_gray">Cancer Treatment Reviews 34, 12<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16491063206620743061" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Zoledronic acid induced IPP/ApppI accumulation in different cancer cell lines</a><div class="gs_gray">H Mönkkönen, I Holen, A Evans, M Jauhiainen, S Auriola, J Mönkkönen</div><div class="gs_gray">Bone 3 (38), 58<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14266448064483725342" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Effects of zoledronic acid on apoptosis in tumour cell lines; repeated low dosing compared to continuous treatment</a><div class="gs_gray">I Holen, R Patel, DV Lefley, HLN Webbe, RE Coleman, JKL Woodward</div><div class="gs_gray">Bone 3 (38), 51-52<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12954012756029137888" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Effects of clodronate on serum osteoprotogerin (OPG) in patients with metastatic bone disease</a><div class="gs_gray">I Holen, RA Hannon, SP Ellis, RE Coleman, JE Brown</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S40-S40<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11323971271645954804" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Zoledronic acid (ZOL) and letrozole (LET) induce synergistic levels of apoptosis in breast cancer cells</a><div class="gs_gray">HL Neville-Webbe, D Lefley, RE Coleman, I Holen</div><div class="gs_gray">Bone 3 (38), 58-59<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10682497434737689780" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Paclitaxel and zoledronic acid induce synergistic increase in apoptotic tumour cell death at clinically relevant concentrations</a><div class="gs_gray">H Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">BONE 34, S67-S68<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2394161141000056769" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:dhFuZR0502QC" class="gsc_a_at">Presence of BRCA1 gene enhances levels of apoptosis induced by combination treatment with doxorubicin (DOX) and zoledronic acid (ZOL)</a><div class="gs_gray">H Neville-Webbe, A Evans, R Coleman, I Holen</div><div class="gs_gray">Breast Cancer Research and Treatment 88<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1307993538816552409" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">OPG is a survival factor for breast-and prostate cancer cells in vitro</a><div class="gs_gray">I Holen, PI Croucher, AC Evans, JM Lippitt, FC Hamdy, RE Coleman, ...</div><div class="gs_gray">Bone 30 (3)<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17346916517988770543" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Inhibiting cytokine-processing enzymes</a><div class="gs_gray">PI Croucher, I Holen, PG Hargreaves</div><div class="gs_gray">Novel Cytokine Inhibitors, 103-122<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13833475791423816216" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Novel Cytokine Inhibitors</a><div class="gs_gray">RA Allen, C Bogdan, ST Crooke, PI Croucher, AL DeFranco, R Foulkes, ...</div><div class="gs_gray">Birkh „user Verlag<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11925216574367369912" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:TQgYirikUcIC" class="gsc_a_at">FREE CME</a><div class="gs_gray">RE Coleman, TA Guise, I Holen, A Lipton, GD Roodman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7659967774502183071" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:OTTXONDVkokC" class="gsc_a_at">Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy</a><div class="gs_gray">LA Quayle, A Spicer, PD Ottewell, I Holen</div><div class="gs_gray">Cancers 13 (16), 3922<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Atomic force microscopy reveals the mechanical properties of breast cancer bone metastases</a><div class="gs_gray">X Chen, R Hughes, N Mullin, RJ Hawkins, I Holen, NJ Brown, JK Hobbs</div><div class="gs_gray">bioRxiv<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Stem cell niches in bone and their roles in cancer metastasis</a><div class="gs_gray">I Holen, L Quayle</div><div class="gs_gray">Elsevier<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Follow Up</a><div class="gs_gray">M Hall</div><div class="gs_gray">Family Practice Guidelines, 210<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:0izLItjtcgwC" class="gsc_a_at">Preventing the progression of breast cancer bone metastasis by CDK inhibition</a><div class="gs_gray">L Saleh, PD Ottewell, JE Brown, SL Wood, NJ Brown, C Wilson, C Park, ...</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 537-538<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:anf4URPfarAC" class="gsc_a_at">Highlights of the last year: basic research</a><div class="gs_gray">I Holen</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 587-587<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:8d8msizDQcsC" class="gsc_a_at">Abstract P2-18-08: Inclusion of adjuvant bone-modifying agents for early breast cancer into standard clinical practice: Challenges and lessons learnt from an international&nbsp;…</a><div class="gs_gray">S Baron-Hay, E Theodoulou, I Porter, C Wilson, I Holen, C Harper-Wynne, ...</div><div class="gs_gray">Cancer Research 80 (4 Supplement), P2-18-08-P2-18-08<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Inclusion of adjuvant bone-modifying agents for early breast cancer into standard clinical practice: Challenges and lessons learnt from an international collaboration</a><div class="gs_gray">S Baron-Hay, E Theodoulou, I Porter, C Wilson, I Holen, C Harper-Wynne, ...</div><div class="gs_gray">CANCER RESEARCH 80 (4)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Metástasis óseas</a><div class="gs_gray">RE Coleman, J Brown, I Holen</div><div class="gs_gray">Abeloff, oncología clínica, 809-830<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:YohjEiUPhakC" class="gsc_a_at">Supracellular Mechanical Architecture of the Intact Bone Microenvironment</a><div class="gs_gray">X Chen, R Hughes, N Mullin, R Hawkins, I Holen, N Brown, J Hobbs</div><div class="gs_gray">EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48, S100-S100<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Breast Cancer Metastasis to Bone: The Role of the Perivascular Niche in Regulating Tumour Cell Dormancy</a><div class="gs_gray">R Hughes, P Ottewell, J Hobbs, I Holen, NJ Brown</div><div class="gs_gray">JOURNAL OF VASCULAR RESEARCH 56, 17-18<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">RUNX/CBFβ transcription factor complexes promote the phenotypic plasticity of metastatic breast cancer cells</a><div class="gs_gray">R Ran, H Harrison, NS Ariffin, R Ayub, HJ Pegg, W Deng, A Mastro, ...</div><div class="gs_gray">bioRxiv, 562538<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Plasma G-CSF levels are predictive of lack of response to zoledronic acid treatment in reducing breast cancer recurrence.</a><div class="gs_gray">JM Ubellacker, N Baryawno, N Severe, MJ DeCristo, J Sceneay, ...</div><div class="gs_gray">MOLECULAR CANCER RESEARCH 16 (8), 68-69<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Abstract B13: Plasma G-CSF levels are predictive of lack of response to zoledronic acid treatment in reducing breast cancer recurrence</a><div class="gs_gray">JM Ubellacker, N Baryawno, N Severe, MJ DeCristo, J Sceneay, ...</div><div class="gs_gray">Molecular Cancer Research 16 (8 Supplement), B13-B13<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Erratum to: Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo</a><div class="gs_gray">I Holen, J Whitworth, F Nutter, A Evans, HK Brown, DV Lefley, I Barbaric, ...</div><div class="gs_gray">Breast Cancer Research 19 (1), 1-2<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Loss of plakoglobin promotes cell-cell contact, increased invasion and breast cancer cell dissemination in vivo (vol 14, pg R86, 2012)</a><div class="gs_gray">I Holen, J Whitworth, F Nutter, A Evans, HK Brown, DV Lefley, I Barbaric, ...</div><div class="gs_gray">BREAST CANCER RESEARCH 19<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Abstract P3-07-14: Targeting ERR-α regulated lactate metabolism eliminates drug-resistant breast cancer cells</a><div class="gs_gray">L Quayle, S Park, DP McDonnell, PD Ottewell, I Holen</div><div class="gs_gray">Cancer Research 77 (4 Supplement), P3-07-14-P3-07-14<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Human specific models for studying ER plus ve and ER-ve breast cancer bone metastasis</a><div class="gs_gray">D Lefley, F Nutter, H Brown, C Tulotta, R Eyre, R Clarke, D Alferez, ...</div><div class="gs_gray">Clinical and Experimental Metastasis 34 (8), 516-516<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Breast Cancer Metastasis To Bone: The Perivascular Niche</a><div class="gs_gray">R Hughes, G Allocca, I Holen, X Chen, J Hobbs, N Brown</div><div class="gs_gray">JOURNAL OF VASCULAR RESEARCH 54, 55-56<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Meet Our Editorial Board Member</a><div class="gs_gray">I Holen</div><div class="gs_gray">Current Cancer Drug Targets 16 (9), 737-737<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:WbkHhVStYXYC" class="gsc_a_at">The SEARCHBreast Portal: A Virtual Bioresource to Facilitate the Sharing of Surplus Animal Materials Derived from Breast Cancer Studies</a><div class="gs_gray">P Carter, K Blyth, I Holen, L Jones, B Morrissey, V Speirs, C Chelala</div><div class="gs_gray">Open Journal of Bioresources 3 (1)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Introducing SEARCHBreast: a virtual resource to facilitate sharing of surplus animal material developed for breast cancer research</a><div class="gs_gray">B Morrissey, I Holen, C Chelala, P Carter, L Jones, K Blyth, V Speirs</div><div class="gs_gray">NPJ breast cancer 2 (1), 1-1<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Peripheral tumour re-growth following combination therapy-role of the bone microenvironment</a><div class="gs_gray">MT Haider, PD Ottewell, NJ Brown, DV Lefley, I Holen</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Blocking IL-1R signalling inhibits breast cancer growth and bone metastases by altering the tumour microenvironment</a><div class="gs_gray">S Bradbury, S Rennicks, A Evans, I Holen, P Ottewell</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Acknowledgement to Reviewers of International Journal of Molecular Sciences in 2015</a><div class="gs_gray">G Abbiati, H Hoffman, O Pelkonen, KL Abbott, SA Hoffman, ...</div><div class="gs_gray">Int. J. Mol. Sci 17, 142<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Metastasis JBO 2016, Journal of Bone Oncology</a><div class="gs_gray">I Holen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Karen Blyth, Phil Carter, Bethny Morrissey, Claude Chelala, Louise Jones</a><div class="gs_gray">I Holen, V Speirs</div><div class="gs_gray">Breast Cancer Res Treat 156, 447-452<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:SP6oXDckpogC" class="gsc_a_at">SEARCHBreast: An online resource designed to increase the efficiency of using materials derived from breast cancer studies in animals.</a><div class="gs_gray">V Speirs, B Morrisey, I Holen, K Blyth, P Carter, C Chelala, L Jones</div><div class="gs_gray">J Pathol<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:dshw04ExmUIC" class="gsc_a_at">The bone microenvironment as a master regulator of tumour cell dormancy in breast cancer-evidence from novel in vivo models</a><div class="gs_gray">P Ottewell, H Brown, G Allocca, MT Haider, N Brown, I Holen</div><div class="gs_gray">European Journal of Cancer 1 (61), S74-S75<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">SEARCHBreast; making surplus material from in vivo models of breast cancer available for research</a><div class="gs_gray">B Morrissey, K Blyth, P Carter, C Chelala, L Jones, I Holen, V Speirs</div><div class="gs_gray">European Journal of Cancer 61 (Supplement 1), S198-S198<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">SHORT-TERM IN VIVO ADMINISTRATION OF CABOZANTINIB INDUCES RAPID MODIFICATION OF THE BONE MARROW VASCULARITY</a><div class="gs_gray">M Haider, I Holen, N Brown, K Hunter</div><div class="gs_gray">Journal of Vascular Research 52<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Mitotic quiescence, but not unique</a><div class="gs_gray">N Wang, F Docherty, H Brown, KJ Reeves, A Fowles, M Lawson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Rapid modification of the bone microenvironment in vivo following short-term cabozantinib administration</a><div class="gs_gray">MT Haider, K Hunter, N Brown, I Holen</div><div class="gs_gray">ECTS-IBMS2015 1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Abstract P2-11-07: Proteins predictive of bone metastasis development in breast cancer patients</a><div class="gs_gray">JA Westbrook, DA Cairns, J Peng, V Speirs, AM Hanby, I Holen, ...</div><div class="gs_gray">Cancer Research 73 (24 Supplement), P2-11-07-P2-11-07<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">首页» 文章» 文章详细信息</a><div class="gs_gray">SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...</div><div class="gs_gray">Breast Cancer Research 15 (5)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">A gap analysis for breast cancer research: identifying translational priorities</a><div class="gs_gray">S Eccles, E Aboagye, S Ali, A Anderson, J Armes, F Berditchevski, ...</div><div class="gs_gray">Breast Cancer Research Review 15 (5), R92<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">characteristic organelle to which the name phagophore has been assigned (Seglen, 1987). The</a><div class="gs_gray">PO Seglen, PB Gordon, I Holen, H Høyvik, AL Kovács, PE Strømhaug, ...</div><div class="gs_gray">Endocytosis: From Cell Biology to Health, Disease and Therapy 62, 247<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Abstract P2-02-04: The interaction between menopausal status and zoledronic acid can differentially affect serum levels of the TGFβ superfamily.</a><div class="gs_gray">C Wilson, MC Winter, I Holen, JV Freeman, AC Evans, RE Coleman</div><div class="gs_gray">Cancer Research 72 (24 Supplement), P2-02-04-P2-02-04<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">The Use of p63 in Distinguishing In Situ and Invasive Tumour in the PyMT Mouse Model of Breast Cancer</a><div class="gs_gray">M Byrne, P Ottewell, I Holen, T Sanderson, S Cross</div><div class="gs_gray">The Journal of Pathology 228<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Bone Oncology—An emerging multi-disciplinary specialty</a><div class="gs_gray">R Coleman, P Hadji</div><div class="gs_gray">Journal of bone oncology 1 (1), 1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:M05iB0D1s5AC" class="gsc_a_at">P2-01-20: Reduced Plakoglobin Expression Increases the Metastatic Potential of Breast Cancer Cells.</a><div class="gs_gray">PD Ottewell, J Whitworth, SS Cross, FH Nutter, I Holen</div><div class="gs_gray">Cancer Research 71 (24 Supplement), P2-01-20-P2-01-20<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">THROMBIN INDUCES OSTEOPROTEGERIN PRODUCTION VIA PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY IN HUMAN MICROVASCULAR ENDOTHELIAL CELLS</a><div class="gs_gray">M Kobayashi-Sakamoto, E Isogai, K Hirose, K Okumura, I Holen, I Chiba</div><div class="gs_gray">INFLAMMATION RESEARCH 60, 216-217<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">PREVENTION OF SPONTANEOUS MAMMARY TUMOUR GROWTH BY SEQUENTIAL ADMINISTRATION OF DOXORUBICIN AND ZOLEDRONIC ACID IN AN IMMUNOCOMPETENT MOUSE MODEL</a><div class="gs_gray">PD Ottewell, H Brown, TL Rogers, DV Lefley, AC Evans, N Wind, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 29-29<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">THE ROLE OF PLAKOGLOBIN IN THE INITIATION OF BREAST CANCER METASTASES</a><div class="gs_gray">PD Ottewell, J Whitworth, I Holen</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 32-32<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:f2IySw72cVMC" class="gsc_a_at">ESCAPE FROM BREAST CANCER THERAPY, ARE NEUROPILINS THE KEY?</a><div class="gs_gray">S Lunj, CA Staton, I Holen, K Ballmer-Hofer, MW Reed, NJ Brown</div><div class="gs_gray">Cancer Research 71<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Towards biomarkers of bone-metastasis using cellular proteomics</a><div class="gs_gray">JA Westbrook, J Peng, DA Cairns, PD Ottewell, I Holen, RE Coleman, ...</div><div class="gs_gray">Bone 1 (48), S33<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Combination vs single agent treatment: The effects of zoledronic acid+/− doxorubicin on breast tumour growth in bone prior to development of osteolytic bone disease</a><div class="gs_gray">HK Brown, PD Ottewell, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">Bone 1 (48), S41<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Changes in osteoblast and osteoclast number rely on direct contact with breast cancer cells—Evidence from a longitudinal study of bone metastasis</a><div class="gs_gray">HK Brown, PD Ottewell, CA Evans, I Holen</div><div class="gs_gray">Bone 1 (48), S40-S41<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Early intervention with a single dose of doxorubicin followed by zoledronic acid induces sustained inhibition of breast cancer-induced bone disease in a mouse model</a><div class="gs_gray">HK Brown, PD Ottewell, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">Bone 2 (48), S255<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">The addition of zoledronic acid to combination chemotherapy decreases circulating serum levels of vascular endothelial growth factor (VEGF) in early breast cancer</a><div class="gs_gray">MC Winter, A Evans, I Holen, RE Coleman</div><div class="gs_gray">Bone 1 (48), S30-S31<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:BqipwSGYUEgC" class="gsc_a_at">10th International Conference on Cancer Induced Bone Disease, 22–25 September 2010, Sheffield, UK</a><div class="gs_gray">J Brown, M Cecchini, R Coleman, P Croucher, T Guise, I Holen, ...</div><div class="gs_gray">Bone 48, S2<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:blknAaTinKkC" class="gsc_a_at">UK innovators in breast cancer: An initiative to support the next generation of breast cancer researchers (on behalf of past and present'UK innovators')</a><div class="gs_gray">JE Brown, D Cameron, R Coleman, L Fallowfield, I Holen, AL Jones, ...</div><div class="gs_gray">Annals of Oncology 22 (S2), ii58<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:0EnyYjriUFMC" class="gsc_a_at">First evidence for anti-tumour effects of doxorubicin and zoledronic acid from an immunocompetent mouse model</a><div class="gs_gray">PD Ottewell, H Brown, CA Evans, NS Wind, NJ Brown, RE Coleman, ...</div><div class="gs_gray">Bone 1 (48), S42<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Does differential expression of CD151 affect the ability of beast cancer cells to establish tumours in bone?</a><div class="gs_gray">NS Winda, H Browna, PD Ottewella, R Sadejb, H Romanskab, ...</div><div class="gs_gray">Abstracts/Bone 48, S22-S55<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Zoledronic Acid Reduces Breast Tumour Growth When Combined with Chemotherapy-Emerging Evidence of Anti-Tumour Effects Outside Bone</a><div class="gs_gray">I Holen, PD Ottewell, RE Coleman</div><div class="gs_gray">CANCER RESEARCH 70<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Abstract P6-14-03: Zoledronic Acid Reduces Breast Tumour Growth When Combined with Chemotherapy—Emerging Evidence of Anti-Tumour Effects Outside Bone</a><div class="gs_gray">I Holen, PD Ottewell, RE Coleman</div><div class="gs_gray">Cancer Research 70 (24 Supplement), P6-14-03-P6-14-03<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Effects of doxorubicin followed by zoledronic acid on early, medium and late stage breast tumour growth in bone</a><div class="gs_gray">HK Brown, PD Ottewell, DV Lefely, RE Coleman, I Holen</div><div class="gs_gray">BONE 47, S318-S319<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Sustained inhibition of tumour growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid</a><div class="gs_gray">PD Ottewell, DV Lefely, SS Cross, RE Coleman, I Holen</div><div class="gs_gray">BONE 47, S317-S317<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Breast cancer-bone marrow stromal cell interactions modify expression of proteolytic enzymes and regulators of bone turnover: P101</a><div class="gs_gray">J Woodward, I Holen, D Lefley, P Ottewell, D Buttle</div><div class="gs_gray">International Journal of Experimental Pathology 91 (2)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Author Index Vol. 47, 2010</a><div class="gs_gray">M Michailidou, HK Brown, DV Lefley, A Evans, SS Cross, RE Coleman, ...</div><div class="gs_gray">Journal of Vascular Research 47 (6), 549-550<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Membership of the ESM</a><div class="gs_gray">M Michailidou, HK Brown, DV Lefley, A Evans, SS Cross, RE Coleman, ...</div><div class="gs_gray">Journal of Vascular Research 47 (6), 545-545<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Thanks to the Reviewers</a><div class="gs_gray">M Michailidou, HK Brown, DV Lefley, A Evans, SS Cross, RE Coleman, ...</div><div class="gs_gray">Journal of Vascular Research 47 (6), 546-548<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Contents Vol. 47, 2010</a><div class="gs_gray">M Michailidou, HK Brown, DV Lefley, A Evans, SS Cross, RE Coleman, ...</div><div class="gs_gray">Journal of Vascular Research 47 (6), I-IV<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Subject Index Vol. 47, 2010</a><div class="gs_gray">M Michailidou, HK Brown, DV Lefley, A Evans, SS Cross, RE Coleman, ...</div><div class="gs_gray">Journal of Vascular Research 47 (6), 551-552<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Bisphosphonates and Bone Diseases: Past, Present and Future</a><div class="gs_gray">AJ Roelofs, K Thompson, FH Ebetino, MJ Rogers, FP Coxon, JE Dunford, ...</div><div class="gs_gray">Current Pharmaceutical Design 16 (27)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Short-term biological effects of zoledronic acid combined with letrozole in postmenopausal women with estrogen receptor-positive invasive breast cancer</a><div class="gs_gray">NJ Bundred, G Landberg, RE Coleman, J Morris, MC Winter, I Holen, ...</div><div class="gs_gray">Journal of Clinical Oncology 27 (15_suppl), e11625-e11625<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid</a><div class="gs_gray">DV Lefley, I Holen, RE Coleman, PD Ottewell</div><div class="gs_gray">Breast Cancer Research 10 (2), 1-1<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:abG-DnoFyZgC" class="gsc_a_at">P15. Zoledronic acid modulates chromosome separation in breast cancer cells by inhibition of Cenp-F prenylation</a><div class="gs_gray">HK Brown, I Holen</div><div class="gs_gray">Cancer Treatment Reviews 34, 18-19<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">PL9. 3. Is the antitumour efficacy of bisphosphonates clinically relevant?</a><div class="gs_gray">I Holen</div><div class="gs_gray">Cancer Treatment Reviews 34, 49<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:8k81kl-MbHgC" class="gsc_a_at">P18. Mechanisms of apoptosis and cell cycle arrest in intra-tibial breast tumours treated sequentially with doxorubicin followed by zoledronic acid</a><div class="gs_gray">P Ottewell, R Coleman, I Holen</div><div class="gs_gray">Cancer Treatment Reviews 34, 19<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Tumour cell-bone marrow stromal cell interactions modify expression of cathepsin K, ADAMTS-15, TIMP-3 and osteoprotegerin (OPG): P044</a><div class="gs_gray">J Woodward, D Lefley, N Cross, P Ottewell, D Buttle, R Coleman, I Holen</div><div class="gs_gray">International Journal of Experimental Pathology 88 (6)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Differential effects of doxorubicin and zoledronic acid on intra-osseous vs extra-osseous breast tumour growth in vivo</a><div class="gs_gray">P Ottewell, B Deux, H Monkkonen, S Cross, R Coleman, P Clezardin, ...</div><div class="gs_gray">Breast Cancer Research and Treatment 106<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Optimizing the yield of circulating DNA from plasma and serum: P2-062</a><div class="gs_gray">X Xue, M Teare, I Holen, Y Zhu, P Woll</div><div class="gs_gray">Journal of Thoracic Oncology 2 (8)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">P2-062: Optimizing the yield of circulating DNA from plasma and serum</a><div class="gs_gray">X Xue, MD Teare, I Holen, YM Zhu, PJ Woll</div><div class="gs_gray">Journal of Thoracic Oncology 2 (8), S514-S515<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Differential effect of doxorubicin and zoledronic acid on intra-osseous vs extra osseous breast tumour growth in vivo</a><div class="gs_gray">PD Ottewell, B Deux, H Monkkonen, RE Coleman, P Clezardin, I Holen</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 22 (7), 1111-1111<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">usos farmacêuticos de bisfosfonatos</a><div class="gs_gray">RE Coleman, I Holen, H Neville-Webbe, CA Evans</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Osteoprotegerin (OPG) expression in breast tumors and bone metastases</a><div class="gs_gray">C VAN POZANK, P Otterwell, S Cross, C Hudis, R COLEMAN, I Holen</div><div class="gs_gray">The International Journal of Biological Markers 22 (1), 83-84<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">The bisphosphonate treatment related ATP analog formation in different cancer cell lines</a><div class="gs_gray">J Kuokkanen, H Monkkonen, A Evans, I Holen, M Jauhiainen, S Auriola, ...</div><div class="gs_gray">BONE 39 (5), S32-S32<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Benefits of combined treatments using antiresorptive agents and cytotoxic drugs</a><div class="gs_gray">I Holen, H Neville-Webbe, RE Coleman</div><div class="gs_gray">Breast Cancer Research 8 (2), 1-1<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Effects of combined treatment with Zometa and Taxol on endothelial cells in vitro</a><div class="gs_gray">M Michailidou, N Brown, RE Coleman, I Holen</div><div class="gs_gray">Breast Cancer Research 8 (2), 1-1<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:maZDTaKrznsC" class="gsc_a_at">Osteoprotegerin is strongly expressed in the intratumoural endothelial cells of gastrointestinal carcinomas</a><div class="gs_gray">S Cross, P Ottewell, M Swinscoe, A Majeed, I Holen</div><div class="gs_gray">The Journal of Pathology 208<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Effects of Zoledronic acid and Paclitaxel on endothelial cells in vitro</a><div class="gs_gray">M Michailidou, HL Neville-Webbe, CA Evans, NJ Brown, RE Coleman, ...</div><div class="gs_gray">Bone 3 (38), 57-58<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Synergistic effects of zoledronic acid and doxorubicin in breast cancer models in vivo</a><div class="gs_gray">PD Ottewell, M Jones, RE Coleman, I Holen</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S30-S30<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">OSTEOPROTEGERIN DERIVED FROM TUMOUR CELLS OR FROM BONE MARROW CELL TYPES DIFFERS IN ITS ACTIVITY AS A SURVIVAL FACTOR FOR PROSTATE CANCER</a><div class="gs_gray">N Cross, E Waterman, N Jokonya, I Holen, F Hamdy, C Eaton</div><div class="gs_gray">European Urology Supplements 2 (5), 124<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">IPP/ApppI production and cellular drug uptake in synergistic action of doxorubicin and zoledronic acid</a><div class="gs_gray">J Kuokkanen, H Mönkkönen, I Holen, CA Evans, HK Kotilainen, S Auriola, ...</div><div class="gs_gray">Bone 3 (38), 54<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Osteoprotegerin (OPG) expression in breast tumours and bone metastases</a><div class="gs_gray">C Van Poznak, P Ottewell, S Cross, C Hudis, RE Coleman, I Holen</div><div class="gs_gray">Bone 3 (38), 31-32<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Rapid increase in levels of circulating osteoprotegerin (OPG) in patients with tumour-induced bone disease following zoledronic acid administration</a><div class="gs_gray">I Holen, D Santini, B Vincenzi, G Tonini, RA Hannon</div><div class="gs_gray">Bone 3 (38), 75<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">There is a general loss of expression of receptor activator of nFkB ligand (RANKL) in human breast cancers but retention of expression has a significant negative association&nbsp;…</a><div class="gs_gray">SS Cross, SP Balasubramanian, JM Lippitt, CA Evans, MWR Reed, ...</div><div class="gs_gray">JOURNAL OF PATHOLOGY 207, 27-27<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Correlations of vessel endothelial growth factor (VEGF) and B crosslinked type I collagen C-telopeptide (bCTX) after a single zoledronic acid infusion in patients with tumour&nbsp;…</a><div class="gs_gray">D Santini, B Vincenzi, RA Hannon, J Brown, A La Cesa, I Holen, G Tonini</div><div class="gs_gray">ANNALS OF ONCOLOGY 16, 32-32<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is expressed in human breast cancers and has a significant negative association with tumours with poor prognosis.</a><div class="gs_gray">SS Cross, SP Balasubramanian, JM Lippitt, CA Evans, MWR Reed, ...</div><div class="gs_gray">JOURNAL OF PATHOLOGY 207, 27-27<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:hMod-77fHWUC" class="gsc_a_at">An integrated analysis of the expression of osteoprotegerin (OPG), tumour necrosis factor-related apoptosis inducing ligand (TRAIL), receptor activator of nFkB ligand (RANKL&nbsp;…</a><div class="gs_gray">SS Cross, RF Harrison, SP Balasubramanian, JM Lippitt, CA Evans, ...</div><div class="gs_gray">JOURNAL OF PATHOLOGY 207, 27-27<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">The effects of zoledronic acid and doxorubicin in combination on breast cancer cell invasion in vitro</a><div class="gs_gray">JKL Woodward, H Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 20 (7), 1299-1299<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Pharmaceutical uses of bisphosphonates</a><div class="gs_gray">RE Coleman, I Holen, H Neville-Webbe, CA Evans</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Tumour endothelial cells express osteoprotegerin (OPG)-A potential role in tumour angiogenesis?</a><div class="gs_gray">SS Cross, Z Yang, JKL Woodward, SP Balasubramanian, MWR Reed, ...</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S37-S38<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Understanding Drug-Sequence Synergistic Induction of Apoptosis by Zoledronic Acid (ZOL) and Doxorubicin (DOX) in Breast Cancer</a><div class="gs_gray">HL Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">Cancer 113 (3), 364-371<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">The combined effects of zoledronic acid (ZOL) and doxorubicin (DOX) on breast cancer cell invasion in vitro</a><div class="gs_gray">J Woodward, R Coleman, H Neville-Webbe, I Holen</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S43-S43<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Differential induction of apoptosis following sequential treatments using cytotoxic drugs and zoledronic acid</a><div class="gs_gray">CA Evans, HL Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S36-S36<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ufrVoPGSRksC" class="gsc_a_at">REVIEW PAPERS</a><div class="gs_gray">TS Benepal, I Judson, JKL Woodward, RE Coleman, I Holen, P Schmid, ...</div><div class="gs_gray">Anti-Cancer Drugs 16<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Osteoprotegerin (OPG) is an autocrine/paracrine survival factor present in bone metastases of prostate cancer</a><div class="gs_gray">C Eaton, R Nyambo, I Holen, N Cross, P Croucher, A Bryden, F Hamdy</div><div class="gs_gray">Prostate Cancer and Prostatic Diseases 7 (4), 378-379<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients</a><div class="gs_gray">CL Eaton, JM Wells, I Holen, PI Croucher, FC Hamdy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis</a><div class="gs_gray">R Nyambo, H Neville-Webbe, I Holen, NA Cross, FC Hamdy, CL Eaton</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Osteoprotegerin is overexpressed in breast cancers and intratumoural endothelial cells and is significantly associated with tumour grade but not with axillary lymph node metastasis</a><div class="gs_gray">SS Cross, SP Balasubramanian, CA Evans, MWR Reed, I Holen</div><div class="gs_gray">JOURNAL OF PATHOLOGY 204, 14A-14A<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Expression of osteoprotegerin (OPG) and TRAIL in oesophageal carcinoma and non-neoplastic gastric and oesophageal mucosa</a><div class="gs_gray">A Spencer, SS Cross, I Holen, R Ackroyd, CJ Stoddard, JP Bury</div><div class="gs_gray">JOURNAL OF PATHOLOGY 204, 50A-50A<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Combined treatments of breast cancer cells using bisphosphonates and doxorubicin</a><div class="gs_gray">HL Neville-Webbe, CA Evans, RE Coleman, I Holen</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19 (6), 1035-1035<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Sequential exposure of breast cancer cells to cytotoxic agents and zoledronic acid induces synergistic increase in apoptotic cell death</a><div class="gs_gray">H Neville-Webbe, A Evans, R Coleman, I Holen</div><div class="gs_gray">Breast Cancer Research and Treatment 88<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Zoledronic acid and TRAIL induce synergistic increase in apoptotic tumor cell death</a><div class="gs_gray">A Evans, H Neville-Webbe, RE Coleman, I Holen</div><div class="gs_gray">BONE 34, S56-S56<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Human breast cancers express osteoprotegerin (OPG), tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and receptor activator of nFkB ligand (RANKL)</a><div class="gs_gray">C Van Poznac, SS Cross, M Saggese, JM Lippitt, C Hudis, RE Coleman, ...</div><div class="gs_gray">BONE 34, S29-S29<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Zoledronic acid and paclitaxel have synergistic antitumor activity and induce apoptotic tumor cell death at clinically relevant concentrations</a><div class="gs_gray">H Neville-Webbe, R Coleman, I Holen</div><div class="gs_gray">Breast Cancer Research and Treatment 88<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Osteoprotegerin expression correlates with ER/PR status in human breast tumors.</a><div class="gs_gray">CH Van Poznak, SS Cross, C Hudis, KS Panageas, RE Coleman, I Holen</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 18, S310-S310<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">The expression of osteoprotegerin co-localises with columnar cell change in human breast tissue</a><div class="gs_gray">SS Cross, C Van Poznak, C Hudis, I Holen</div><div class="gs_gray">JOURNAL OF PATHOLOGY 201, 32A-32A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Source of maternal serum osteoprotegerin during human pregnancy</a><div class="gs_gray">KE Naylor, A Rogers, C Smith, V Hall, RB Fraser, I Holen, J Lippitt, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 18 (7), 1376-1376<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:k_IJM867U9cC" class="gsc_a_at">Bone marrow stromal cell-derived osteoproteger in (OPG) protects breast cancer cells from trail-induced apoptosis</a><div class="gs_gray">HL Neville-Webbe, A Evans, C Eaton, R Coleman, I Holen</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S25-S25<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Human bone marrow stromal cells (hBMSC) protect prostate cancer cells from trail induced apoptosis</a><div class="gs_gray">R Nyambo, NA Cross, J Lippit, I Holen, AAG Bryden, CL Eaton</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S26-S26<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines</a><div class="gs_gray">S Chandrasekharan, DJ Buttle, I Holen, NA Cross, FC Hamdy</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) are expressed in human breast tumors</a><div class="gs_gray">C Van Poznak, S Cross, C Hudis, L Norton, K Panageas, R Coleman, ...</div><div class="gs_gray">Breast Cancer Research and Treatment 82<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:a0OBvERweLwC" class="gsc_a_at">Expression pattern of the ADAMTS proteinases in human prostate cancer cell lines</a><div class="gs_gray">S Chandrasekharan, FC Hamdy, I Holen, N Cross, DJ Buttle</div><div class="gs_gray">European Urology Supplements 1 (2), 60<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Expression pattern of the ADAMTS proteinases in human prostate cancer cell lines</a><div class="gs_gray">S Chandrasekharan, FC Hamdy, I Holen, N Cross, DJ Buttle</div><div class="gs_gray">European Urology Supplements 1 (2), 60<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">The role of osteoprotegerin in breast and prostate cancer</a><div class="gs_gray">I Holen, JM Wells, PI Croucher, CA Evans, JM Lippitt, RE Coleman, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 17 (7)<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.</a><div class="gs_gray">I Holen, JM Wells, PI Croucher, FC Hamdy, CL Eaton</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Serum osteoprotegerin levels are increased in hormone resistant prostate cancer patients</a><div class="gs_gray">J Wells, I Holen, P Croucher, F Hamdy, C Eaton</div><div class="gs_gray">European Urology Supplements 1 (1), 159<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Production of osteoprotegerin by prostate cancer cells suppresses trial induced apoptosis</a><div class="gs_gray">I Holen, C Eaton, F Hamdy, P Croucher</div><div class="gs_gray">European Urology Supplements 1 (1), 54<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Investigations into the proteolytic activity of recombinant human ADAMTS-5</a><div class="gs_gray">MZ Ilic, CJ Handley, MN Vankemmelbeke, GC Jones, I Holen, AJ Day, ...</div><div class="gs_gray">London, United Kingdom: The Biochemical Society,<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.</a><div class="gs_gray">CM Shipman, I Holen, JM Lippitt, T Edwards, PI Croucher</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 15 (6)<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Human myeloma cells shed syndecan-1 in vitro: Evidence for mediation by a non-matrix metallproteinase.</a><div class="gs_gray">I Holen, NL Dury, PG Hargreaves, PI Croucher</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 15 (6), 1222-1222<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Aggrecanases in Joint Capsule</a><div class="gs_gray">CJ Handley, HC Robinson, DJ Buttle, I Holen, MH Van Kemmetfeke, ...</div><div class="gs_gray">Parkville, Australia: Matrix Biology Society of Australia and New Zealand,<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Bovine joint capsule and fibroblasts derived from joint capsule express aggrecanase activity</a><div class="gs_gray">CJ Handley, HC Robinson, DJ Buttle, I Holen, MN Vankenamelbeke, ...</div><div class="gs_gray">Amsterdam, Netherlands: Elsevier,<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Regulation of hepatocellular growth, autophagy and cytoskeletal structure by protein kinases and protein phosphatases</a><div class="gs_gray">H Blankson, I Holen, T Grotmol, PO Seglen</div><div class="gs_gray">CELL BIOLOGY AND TOXICOLOGY 13, 42-42<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:UebtZRa9Y70C" class="gsc_a_at">IOS Press, 1997</a><div class="gs_gray">PE STRØMHAUG, M FENGSRUD, TO BERG, MTN MØLLER, ...</div><div class="gs_gray">Proteolysis in Cell Functions 13, 357<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:qjMakFHDy7sC" class="gsc_a_at">IOS Press, 1997</a><div class="gs_gray">PE STRØMHAUG, M FENGSRUD, TO BERG, MTN MØLLER, ...</div><div class="gs_gray">Proteolysis in Cell Functions 13, 357<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:UxriW0iASnsC" class="gsc_a_at">Intracellular Signalling Systems Involved in Regulation of Autophagy and Endocytosis in Isolated Rat Hepatocytes</a><div class="gs_gray">I Holen</div><div class="gs_gray">Norwegian Cancer Society<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Role of Calcium, Protein Phosphorylation and the Cytoskeleton in Hepatocytic Autophagy</a><div class="gs_gray">PO Seglen, I Holen, PB Gordon</div><div class="gs_gray">Molecular Mechanisms of Membrane Traffic, 339-349<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Regulation of autophagy by calcium and protein phosphorylation</a><div class="gs_gray">PO Seglen, I Holen, M Fosse, PB Gordon</div><div class="gs_gray">Proteolysis and Protein Turnover: Proceedings of the 9th ICOP Meeting&nbsp;…<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Optimizing the yield and utility of circulating cell-free DNA from plasma and serum</a><div class="gs_gray">MD Teare, I Holen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">journal homepage: www. elsevier. com/locate/jbo</a><div class="gs_gray">I Kuchuk, B Hutton, P Moretto, T Ng, CL Addison, M Clemons, AJ Lomax, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">of Zoledronic Acid to Chemotherapy in breast cancer</a><div class="gs_gray">MC Winter, SS Cross, CE Ingram, IJ Jolley, I Holen, MQ Hatton, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Zoledronic acid has differential anti-tumour activity in the pre-and post-menopausal bone</a><div class="gs_gray">PD Ottewell, N Wang, HK Brown, KJ Reeves, CA Fowles, PI Croucher, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=9lxA1jEAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=9lxA1jEAAAAJ:738O_yMBCRsC" class="gsc_a_at">journal homepage: www. elsevier. com/locate/jbo</a><div class="gs_gray">M Oda, K Iwaya, R Kikuchi, T Kobayashi, T Yoneda, K Nishikawa, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–291</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>